HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, Tanzania.
This in-vitro diagnostic (IVD) study in infants born to HIV infected mothers evaluates the reliability and operational feasibility of an HIV Point-of-Care (PoC) test for HIV early infant diagnosis (EID) in a public health setting at obstetric clinics in Mbeya, Tanzania. Recruitment is planned to take place at 4 obstetric/maternity study sites in and around Mbeya over a time period of 12 months. The HIV PoC test will be validated against the Standard-of-Care diagnostic test, i.e. Dried Blood Spot (DBS) analyses. The PoC test under investigation is the Xpert HIV-1 Qual produced by Cepheid, Sunnyvale, USA.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
604
Ex-vivo performed diagnostic blood based test.
NIMR - Mbeya Medical Research Centre
Mbeya, Tanzania
Specificity of PoC HIV test
Specificity of the PoC HIV test
Time frame: Participants are planned to be followed for the duration of 6 weeks, i.e. the time point of the current Standard of Care EID
Sensitivity of PoC HIV test
Sensitivity of the PoC HIV test
Time frame: Participants are planned to be followed for the duration of 6 weeks, i.e. the time point of the current Standard of Care EID
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.